The timing of cranial radiation in elderly patients with newly diagnosed glioblastoma multiforme

Neuro-Oncology

Volumn 12, Issue 2, 2010, Pages 190-198

  Lai, Rose ^a   Hershman, Dawn L ^b   Doan, Tieu ^b,c   Neugut, Alfred I ^b,c  

^a NEUROLOGICAL INSTITUTE   (United States)

^b NONE   (United States)

^c NONE   (United States)

Author keywords

Elderly; Glioblastoma multiforme; Radiation delay; SEER Medicare; Waiting time

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; ELDERLY CARE; GLIOBLASTOMA; HUMAN; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; POSTOPERATIVE CARE; PROGNOSIS; SKULL IRRADIATION; TUMOR BIOPSY;

AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; COMBINED MODALITY THERAPY; CRANIAL IRRADIATION; GLIOBLASTOMA; HUMANS; KAPLAN-MEIERS ESTIMATE; PROPORTIONAL HAZARDS MODELS; SEER PROGRAM; TIME;

EID: 75849139026     PISSN: 15228517     EISSN: 15235866     Source Type: Journal    
DOI: 10.1093/neuonc/nop004     Document Type: Article

References (22)

1. Keime-Guibert F, Chinot O, Taillandier L, et al. Radiotherapy for glioblastoma in the elderly. N Engl J Med. 2007;356:1527-1535.
2. Roa W, Brasher PM, Bauman G, et al. Abbreviated course of radiation therapy in older patients with glioblastoma multiforme: a prospective randomized clinical trial. J Clin Oncol. 2004;22:1583-1588.
3. Burnet NG, Jena R, Jefferies SJ, et al. Mathematical modelling of survival of glioblastoma patients suggests a role for radiotherapy dose escalation and predicts poorer outcome after delay to start treatment. Clin Oncol (R Coll Radiol). 2006;18:93-103.
4. Mirimanoff RO, Gorlia T, Mason W, et al. Radiotherapy and temozolomide for newly diagnosed glioblastoma: recursive partitioning analysis of the EORTC 26981/22981-NCIC CE3 Phase III Randomized Trial. J Clin Oncol. 2006;24:2563-2569.
5. Irwin C, Hunn M, Purdie G, et al. Delay in radiotherapy shortens survival in patients with high-grade glioma. J Neurooncol. 2007;85:339-343.
6. Blumenthal DT, Berkey B, Nelson D, et al. "Short" delay in initiation of radiotherapy may not affect the outcome of patients with GBM: a secondary analysis from the RTOGdatabase. Neuro-Oncology. 2006;8:483.
7. Do V, Gebski V, Barton MB. The effect of waiting for radiotherapy for grade III/IV gliomas. Radiother Oncol. 2000;57:131-136.
8. Hutchins LF, Unger JM, Crowley JJ, et al. Underrepresentation of patients 65 years of age or older in cancer-treatment trials. N Engl J Med. 1999;341:2061-2067.
9. Potosky AL, Riley GF, Lubitz JD, et al. Potential for cancer-related health services research using a linked Medicare-tumor registry database. Med Care. 1993;31:732-748.
10. Krieger N. Overcoming the absence of socioeconomic data in medical records: validation and application of a census-based methodology. Am J Public Health. 1992;82:703-710.
11. Klabunde CN, Potosky AL, Legler JM, et al. Development of a comorbidity index using physician claims data. J Clin Epidemiol. 2000;53:1258-1267.
12. Klabunde CN, Warren JL, Legler JM. Assessing comorbidity using claims data: an overview. Med Care. 2002;40(8 Suppl):IV-26-IV-35.
13. Grambsch P, Therneau T. Proportional hazard tests in diagnostic based on weighted residuals. Biometrika. 1994;81:515-526.
14. Lamborn KR, Chang SM, Prados MD. Prognostic factors for survival of patients with glioblastoma: recursive partitioning analysis. Neuro Oncol. 2004;6:227-235.
15. E C, Dahrouge S, Samant R, et al. Radical radiotherapy for cervix cancer: the effect of waiting time on outcome. Int J Radiat Oncol Biol Phys. 2005;61:1071-1077.
16. Hershman DL, Wang X, McBride R, et al. Delay in initiating adjuvant radiotherapy following breast conservation surgery and its impact on survival. Int J Radiat Oncol Biol Phys. 2006;65:1353-1360.
17. Gorlia T, van den Bent MJ, Hegi ME, et al. Nomograms for predicting survival of patients with newly diagnosed glioblastoma: prognostic factor analysis of EORTC and NCIC Trial 26981-22981/CE.3. Lancet Oncol. 2008;9:29-38.
18. Yung WK, Albright RE, Olson J, et al. A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse. Br J Cancer. 2000;83:588-593.
19. Stewart LA. Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials. Lancet. 2002;359:1011-1018.
20. Stupp R, Mason WP, van den Bent MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 2005;352:987-996.
21. Brandes AA, Vastola F, Basso U, et al. A prospective study on glioblastoma in the elderly. Cancer. 2003;97:657-662.
22. Combs SE, Wagner J, Bischof M, et al. Postoperative treatment of primary glioblastoma multiforme with radiation and concomitant temozolomide in elderly patients. Int J Radiat Oncol Biol Phys. 2008;70: 987-992.